Department of Medicine
Michael Drazer is a physician-scientist who works at the intersection of human genetics, hematology, and patient care. He has developed a series of cellular models that accurately reproduce genetic mutations that are found in patients and used these to determine how individual genetic changes impact molecular pathways that increase the risk for blood cancers. He has used a number of methods, including gene editing, cell sequencing, transcriptomics, and cellular models, to determine if these mutations lead to increased cancer risk and to inform the development of treatments specific to patients with hereditary blood cancers.
His research has been published in Journal of Clinical Oncology, JAMA, Cancer, Seminars in Oncology, Annals of Internal Medicine, Haematologica, Human Molecular Genetics, Stem Cell Reports, Genetics in Medicine, Current Hematologic Malignancy Reports, Human Mutation, Journal of Medical Economics, Leukemia, Blood, and Blood Advances. He is the recipient of young investigator awards from the Cancer Research Foundation and the Edward P. Evans Foundation. He also has been supported by the Damon Runyon Cancer Research Foundation’s Physician-Scientist Training Award.
Drazer earned a BA summa cum laude in English and biochemistry, as well as a BS summa cum laude in biology, from Indiana University, where he was a Wells Scholar. He received an MD from the University of Chicago Pritzker School of Medicine and a PhD from the Department of Human Genetics at the University of Chicago. He completed his residency in internal medicine and a fellowship in hematology and oncology at the University of Chicago.